{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:16:46Z","timestamp":1789881406482,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.contraception.2014.11.008","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T13:18:04Z","timestamp":1416230284000},"page":"134-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects"],"prefix":"10.1016","volume":"91","author":[{"given":"Y.","family":"Zimmerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Foidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pintiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Minon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.J.M.","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Cobey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.T.","family":"Coelingh Bennink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2014.11.008_bb0005","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1743-6109.2011.02597.x","article-title":"Sexual behavior and oral contraception: a pilot study","volume":"9","author":"Battaglia","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/jsm.12392","article-title":"Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study","volume":"11","author":"Battaglia","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0015","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1743-6109.2012.02848.x","article-title":"The effects of hormonal contraceptives on female sexuality: a review","volume":"9","author":"Burrows","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0020","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1111\/jsm.12310","article-title":"Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction","volume":"10","author":"Davis","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2011.10.007","article-title":"Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users","volume":"85","author":"Elaut","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.008_bb0030","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.psyneuen.2012.11.006","article-title":"Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill \u2014 a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive","volume":"38","author":"Gingnell","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.contraception.2014.11.008_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(01)00218-9","article-title":"A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation","volume":"64","author":"Sanders","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.008_bb0040","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/jsm.12409","article-title":"Hormonal contraception and female pain, orgasm and sexual pleasure","volume":"11","author":"Smith","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.contraception.2009.12.022","article-title":"Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students","volume":"82","author":"Wallwiener","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.008_bb0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.11.008_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(95)00074-K","article-title":"Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation","volume":"51","author":"Rosenberg","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.008_bb0060","doi-asserted-by":"crossref","first-page":"412.e1","DOI":"10.1016\/j.ajog.2006.12.015","article-title":"Oral contraceptive discontinuation: do side effects matter?","volume":"196","author":"Westhoff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.11.008_bb0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.maturitas.2009.02.011","article-title":"Role of testosterone in the treatment of hypoactive sexual desire disorder","volume":"63","author":"Schwenkhagen","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2014.11.008_bb0070","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0015-0282(02)02969-2","article-title":"Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment","volume":"77","author":"Bachmann","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2014.11.008_bb0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jsbmb.2013.05.006","article-title":"Androgen treatment of postmenopausal women","volume":"142","author":"Davis","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2014.11.008_bb0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/01.GME.0000060256.03945.20","article-title":"Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women","volume":"10","author":"Goldstat","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.contraception.2014.11.008_bb0085","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00404-013-2969-7","article-title":"Androgen therapy in women: for whom and when","volume":"288","author":"Pluchino","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2014.11.008_bb0090","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1743-6109.2007.00584.x","article-title":"Are the Endocrine Society's clinical practice guidelines on androgen therapy in women misguided? A commentary","volume":"4","author":"Traish","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2014.11.008_bb0100","series-title":"I Endocrine effects Contraception","article-title":"Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive","author":"Zimmerman","year":"2014"},{"key":"10.1016\/j.contraception.2014.11.008_bb0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10532528.2004.10559822","article-title":"Oral contraceptives and libido in women","volume":"15","author":"Davis","year":"2004","journal-title":"Annu Rev Sex Res"},{"key":"10.1016\/j.contraception.2014.11.008_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jama.294.1.91","article-title":"Circulating androgen levels and self-reported sexual function in women","volume":"294","author":"Davis","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2014.11.008_bb0115","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1517\/14656566.2.9.1367","article-title":"Oral contraceptives and mood","volume":"2","author":"Kahn","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.contraception.2014.11.008_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-0327(01)00356-1","article-title":"To what extent do oral contraceptives influence mood and affect?","volume":"70","author":"Oinonen","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.contraception.2014.11.008_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/13625187.2012.728643","article-title":"The influence of combined oral contraceptives on female sexual desire: a systematic review","volume":"18","author":"Pastor","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2014.11.008_bb0130","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0412.2011.01333.x","article-title":"Adverse mood symptoms with oral contraceptives","volume":"91","author":"Poromaa","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2014.11.008_bb0135","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.psyneuen.2006.12.011","article-title":"Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women?","volume":"32","author":"Graham","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.contraception.2014.11.008_bb0140","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1743-6109.2006.00294.x","article-title":"Comparison of androgens in women with hypoactive sexual desire disorder: those on combined oral contraceptives (COCs) vs. those not on COCs","volume":"3","author":"Warnock","year":"2006","journal-title":"J Sex Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0145","first-page":"3208","article-title":"Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects","volume":"85","author":"Legrain","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2014.11.008_bb0150","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1177\/00912700122012742","article-title":"Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women","volume":"41","author":"Meno-Tetang","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2014.11.008_bb0155","first-page":"1360","article-title":"Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age","volume":"78","author":"Morales","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2014.11.008_bb0160","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1210\/jcem.83.6.4850","article-title":"Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression","volume":"83","author":"Arlt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2014.11.008_bb0165","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00006842-196811000-00006","article-title":"The development of a menstrual distress questionnaire","volume":"30","author":"Moos","year":"1968","journal-title":"Psychosom Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0170","series-title":"Menstrual distress questionnaire \u2014 manual","author":"Moos","year":"1991"},{"key":"10.1016\/j.contraception.2014.11.008_bb0175","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1023\/A:1008925906947","article-title":"The McCoy female sexuality questionnaire","volume":"9","author":"McCoy","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.contraception.2014.11.008_bb0180","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.contraception.2014.11.008_bb0185","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.01.014","article-title":"Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen","volume":"75","author":"Coffee","year":"2007","journal-title":"Contraception"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2014.11.008_bb0190","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3109\/13625187.2010.529969","article-title":"New regimens with combined oral contraceptive pills\u2013moving away from traditional 21\/7cycles","volume":"15","author":"Read","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2014.11.008_bb0195","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s10508-013-0126-9","article-title":"An evolutionary approach offers a fresh perspective on the relationship between oral contraception and sexual desire","volume":"42","author":"Roberts","year":"2013","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.contraception.2014.11.008_bb0200","first-page":"79","article-title":"Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life","volume":"48","author":"Borenstein","year":"2003","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/11535450-000000000-00000","article-title":"Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study","volume":"30","author":"Kelly","year":"2010","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.contraception.2014.11.008_bb0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.008_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2005.02.002","article-title":"Prospective study on sexual behavior of women using 30 microg ethinylestradiol and 3mg drospirenone oral contraceptive","volume":"72","author":"Caruso","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.008_bb0220","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1743-6109.2011.02208.x","article-title":"Conventional vs. extended-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3mg drospirenone and 20 microg ethinyl estradiol","volume":"8","author":"Caruso","year":"2011","journal-title":"J Sex Med"},{"issue":"Suppl. 4","key":"10.1016\/j.contraception.2014.11.008_bb0225","first-page":"S17","article-title":"A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido","volume":"89","author":"Oranratanaphan","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.contraception.2014.11.008_bb0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01541939","article-title":"Oral contraceptives, androgens, and the sexuality of young women: II. The role of androgens","volume":"20","author":"Bancroft","year":"1991","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.contraception.2014.11.008_bb0235","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1111\/j.1743-6109.2011.02409.x","article-title":"Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V\/DNG) oral contraceptive on the quality of sexual life","volume":"8","author":"Caruso","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0240","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0010-7824(95)00226-X","article-title":"The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods","volume":"52","author":"Graham","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.008_bb0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2007.04.002","article-title":"The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol","volume":"76","author":"Greco","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.008_bb0250","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/00926230600666311","article-title":"Hormonal contraception and sexual desire: a critical review","volume":"32","author":"Schaffir","year":"2006","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.contraception.2014.11.008_bb0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.contraception.2010.02.016","article-title":"Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels","volume":"82","author":"Strufaldi","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.008_bb0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/713605033","article-title":"The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women","volume":"4","author":"Laan","year":"2001","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2014.11.008_bb0265","series-title":"Presented at the Annual Meeting of the European Society of Human Reproduction and Embryology","article-title":"Two randomised clinical studies investigating the endocrine and clinical effects of normalising testosterone levels during oral contraception","author":"Zimmerman","year":"2014"},{"key":"10.1016\/j.contraception.2014.11.008_bb0270","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1210\/jc.2009-0672","article-title":"A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency","volume":"94","author":"Alkatib","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2014.11.008_bb0275","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1073\/pnas.97.8.4279","article-title":"Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue","volume":"97","author":"Baulieu","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.contraception.2014.11.008_bb0280","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2008-1982","article-title":"Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial","volume":"94","author":"Binder","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2014.11.008_bb0285","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1210\/jc.2010-2888","article-title":"Clinical review: DHEA replacement for postmenopausal women","volume":"96","author":"Davis","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2014.11.008_bb0290","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00126334-199305000-00005","article-title":"An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease","volume":"6","author":"Dyner","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2014.11.008_bb0295","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa054629","article-title":"DHEA in elderly women and DHEA or testosterone in elderly men","volume":"355","author":"Nair","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2014.11.008_bb0300","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.maturitas.2009.03.020","article-title":"The safety of 52weeks of oral DHEA therapy for postmenopausal women","volume":"63","author":"Panjari","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2014.11.008_bb0305","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3945\/ajcn.2008.27265","article-title":"Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone","volume":"89","author":"Weiss","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.contraception.2014.11.008_bb0310","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"7","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2014.11.008_bb0315","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejogrb.2010.12.027","article-title":"Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 mug plus drospirenone 3mg administered in a 24\/4 regimen: a pooled analysis","volume":"155","author":"Koltun","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2014.11.008_bb0320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.008_bb0325","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progestogens with antiandrogenic properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2014.11.008_bb0330","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1111\/j.1610-0387.2009.07171.x","article-title":"Hormonal antiandrogens in acne treatment","volume":"8","author":"Zouboulis","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.contraception.2014.11.008_bb0335","first-page":"103","article-title":"Effects of sex steroids on skin 5 alpha-reductase activity in vitro","volume":"78","author":"Cassidenti","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.11.008_bb0340","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09513590009167685","article-title":"Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro","volume":"14","author":"Rabe","year":"2000","journal-title":"Gynecol Endocrinol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414007793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414007793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:00:06Z","timestamp":1747162806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782414007793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0010782414007793"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.11.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}